GPX7 and neoplasm: Besides, GPX7 expression was found to be significantly correlated with additional pharmaceutical therapy (p = 0.0054), primary therapy outcome success (p = 0.000038), new tumor event after initial treatment (p = 0.0000029), Postoperative rx tx (p = 0.038), radiation therapy (p = 0.0000000013), sensory changes (p = 0.0027) and visual changes (p = 0.01) (Supplementary Table S1) in TCGA cohort.